DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 94 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactResults

Suven Life Sciences Limited — Board Meeting Intimation

NSE 1 hr ago·29 Oct 2026, 10:29 am

Suven Life Sciences

Suven Life Sciences has announced a board meeting scheduled for November 5, 2026. The primary agenda for this meeting is to review and approve the company's unaudited financial results for the first half of the fiscal year 2026-27, which covers the period ending September 2026.

This announcement is significant for investors as it signals the upcoming release of key performance data. The unaudited results will provide an early glimpse into the company's operational health and financial trajectory for the current half-year, helping investors gauge its progress against market expectations.

Investors should watch for the release of the financial statements following the board's approval. The data will be crucial for assessing the company's growth momentum and may influence short-term trading sentiment in the stock.